CDR

Sandoz Strategizes Quick Launch of Generic Ozempic in Canada

12 days ago

Sandoz, a subsidiary of Novartis, has unveiled its plans to swiftly introduce a generic version of the diabetes medication Ozempic in Canada. This move comes amid rising demand for affordable diabetes treatment options in the country, where the cost of medications has been a significant concern for many patients and healthcare providers alike.

OECD Warns UK’s Fiscal Policies are Unsustainable Without Increased Taxation

19 days ago

The Organization for Economic Co-operation and Development (OECD) released a report on December 4, 2024, raising alarms about the United Kingdom's fiscal approach, emphasizing that the current financial stance is unsustainable unless significant tax increases are implemented. The assessment comes in light of ongoing challenges the UK faces concerning its public finances.

Canadian Pharma Giant Apotex Sets Stage for IPO with Bank Selection

2 months ago

In a significant move that signals its intent to go public, Apotex Inc., a leading Canadian pharmaceutical manufacturer, has engaged several banks to help navigate the intricacies of an initial public offering (IPO). This strategy comes at a time when the market for pharmaceutical stocks is showing strong performance, and Apotex aims to capitalize on this momentum to enhance its growth trajectory and visibility.

CD&R Takes Strategic Steps to Alleviate French Concerns Over Sanofi Acquisition

2 months ago

In a proactive effort to address rising concerns from the French government regarding its acquisition of Sanofi, private equity firm Clayton, Dubilier & Rice (CD&R) is reportedly preparing to implement measures aimed at easing these apprehensions. The initiatives come as the proposed purchase of the French pharmaceutical giant by CD&R has stirred significant trepidation among stakeholders in France, particularly in light of the country's focus on safeguarding its strategic industries.

France Contemplates State Stake in Sanofi’s Asset Sale to CD&R

2 months ago

In a pivotal move that could redefine the landscape of France's healthcare sector, the French government is considering acquiring a stake in a Sanofi subsidiary that is currently set to be sold to the private equity firm Clayton, Dubilier & Rice (CD&R). This potential stake acquisition comes as Sanofi, a leading global biopharmaceutical company, seeks to divest certain assets to focus on its core operations and enhance its strategic initiatives.

Pharmaceutical Game Changer: Mounjaro and Zepbound Supply Shortage Resolved

3 months ago

In a welcome breakthrough for both pharmaceutical companies and patients dependent on vital obesity and diabetes medicines, supply shortages of Mounjaro and Zepbound have finally been resolved. These medicines, which play a vital role in the management of diabetes and weight loss, were under short supply resulting from unforeseen demand and complex interruptions in supply. Recently, there has been promising news in the announcements of drug manufacturers as early signals of stabilization in the availability of these vital drugs have shown signs.